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Members of the herpesviridae family including
Kaposi’s sarcoma-associated herpesvirus
(KSHV) persist latently in their hosts and harbor
their genomes as closed circular episomes.
Propagation of the KSHV genome into new
daughter cells requires replication of the
episome once every cell division and is consid-
ered critically dependent on expression of the vi-
rus encoded latency-associated nuclear antigen
(LANA). This study demonstrates a LANA-inde-
pendentmechanismofKSHV latentDNA replica-
tion. A cis-acting DNA element within a discreet
KSHVgenomic region termed the longunique re-
gion (LUR) can initiate and support replication of
plasmids lacking LANA-binding sequences or
a eukaryotic replication origin. The human cellu-
lar replication machinery proteins ORC2 and
MCM3 associated with the LUR element and de-
pletion of cellular ORC2 abolished replication of
the plasmids indicating that recruitment of the
host cellular replication machinery is important
for LUR-dependent replication. Thus, KSHV can
initiate replication of its genome independent of
any trans-acting viral factors.
INTRODUCTION
Members of the herpesviridae family share the character-
istic feature of persisting latently in their natural hosts and
typically harbor viral genomes as closed circular episomes
(Roizman, 1996). Latent replication is thought to proceed
fromadefined origin, typically with the expression of a viral
encoded protein for maintenance of the viral episomes
(Roizman, 1996). Kaposi’s sarcoma-associated herpesvi-
rus (KSHV/HHV8) primarily infects the human endothelial
cells and B lymphocytes and shares similar genomic char-
acteristics to Epstein Barr virus (EBV) (Roizman, 1996).
KSHV is tightly associated with the development of KS
as well as two other lymphoproliferative diseases: primary
effusion lymphoma (PEL) and Multicentric Castleman’s
disease (MCD) (Verma et al., 2007).
KSHV is a member of the Rhadinovirus genera of the
gammaherpesvirinae subfamily (Russo et al., 1996). The106 Cell Host & Microbe 2, 106–118, August 2007 ª2007 Elseviemost closely related human herpesvirus is EBV, the proto-
typic member of the other gammaherpesvirinae genera,
Lymphocryptovirus (Kieff, 1996; Russo et al., 1996).
Similar to EBV, KSHV infection within tumor cells is
predominantly latent and expresses a limited number of
viral genes which include LANA, viral cyclin, and viral Fas-
associated death domain (FAAD) interleukin-1B-convert-
ing enzyme (FLICE) inhibitory protein (v-FLIP) (Verma
et al., 2007).
The KSHV latency-associated nuclear antigen (LANA)
functions in both transcription (Verma and Robertson,
2003a) and plasmid maintenance (Ballestas et al., 1999;
Cotter and Robertson, 1999). LANA is a large, 222–234
kDa nuclear protein expressed in virtually all KSHV latently
infected cells (Kedes et al., 1997; Rainbow et al., 1997),
protects against cell death by inhibition of p53-mediated
transcription (Friborg et al., 1999; Verma and Robertson,
2003a), and regulates p53 and VHL through recruitment
of the EC5S ubiquitin E3 ligase (Cai et al., 2006). Viral cyclin
associates with cdk6 and phosphorylates human ORC1,
promoting S phase entry for origin firing and replication
(Laman et al., 2001a, 2001b).
Replication of latent EBV episomes requires the viral
cis-acting element, oriP, and a trans-acting viral protein
EBNA-1 bound to oriP DNA consisting of the family of
repeats (FR) and dyad symmetry element (DS) and recruits
the host cellular replication machinery (Rawlins et al.,
1985; Reisman et al., 1985). The FR provides EBNA-1-
binding sites important for anchoring the EBV episome
to the nuclear matrix (Jankelevich et al., 1992). The DS
element contains 4 EBNA-1-binding sites, and replication
appears to initiate at or immediately adjacent to the DS
element, although DS-independent EBV replication has
been reported (Gahn and Schildkraut, 1989; Little and
Schildkraut, 1995).
LANA has been suggested to play a role in partitioning
of the viral genome during mitosis, as a recombinant
KSHV virus (BAC36DLANA) disrupted for LANA expres-
sion was inefficient in maintenance of the viral episomes
(Ye et al., 2004). However, a recent report using short hair-
pin RNA (shRNA) to knock down the oncogenic latent
gene cluster, including LANA, led to the reduction of
KSHV genomic copies to a low, but steady, copy number
(Godfrey et al., 2005).
Previous studies have shown that LANA is critical for
replication of KSHV TR-containing plasmids suggesting
the presence of a LANA-dependent origin within the TR.
However, knockdown of LANA was unable to eliminater Inc.
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2005). Thus, additional ori sites within the KSHV genome
may function independent of LANA. In this report, we
have demonstrated that a KSHV cis-acting DNA element
within the KSHV long unique region (LUR) allowed for
replication of a plasmid lacking a eukaryotic replication
origin and LANA-binding sequence, which suggests the
presence of a functional origin. Plasmids containing this
region of the KSHV genome incorporate BrdU, precipitate
with chromatin-bound cellular replication machinery
proteins ORC2 and MCM3, and replicate independent of
any viral protein expressed in trans. Hence, this represents
a potential unique mechanism for KSHV replication and
suggests the possibility for development as a vector sys-
tem for long-term maintenance of episomal DNA without
integration or gene transfer by ex vivo strategies.
RESULTS
A cis-Acting Element within the Long Unique Region
of KSHV GenomeReplicates in Transient Replication
Assays
Previous studies demonstrated that Z6, the 33 kbp left end
of the KSHV genome, binds to LANA with high affinity and
therefore is hypothesized to contain cis-acting elements
important for DNA maintenance (Cotter and Robertson,
1999). The terminal repeat (TR) provides binding sites for
LANA and is important for tethering of the viral episomes
to the host chromosomes (Moore and Chang, 2003;
Verma and Robertson, 2003a). TR supports replication
of plasmids in eukaryotic cells (Grundhoff and Ganem,
2003; Hu et al., 2002; Verma et al., 2006). However, the
replication potential of other regions of the genome was
not extensively evaluated. Here we used a vector,
pBSpuro, which lacks a eukaryotic origin of replication
and contains a puromycin acetyl transferase (Pac) gene,
for the screening of replication potential of the Z6 frag-
ments. Cloning of Z6 DNA fragments into pBSpuro
allowed straightforward screening of the candidate viral
cis-acting elements capable of replication. Only insert(s)
that complemented the absence of an origin in the vector
provided puromycin resistance to the transfected cells
after replication and maintenance of the plasmids.
The Z6 fragments cloned into the pBSpuro vector at the
respective enzyme sites (Figure 1A). Hirt DNA extracted
from 293 cells with these plasmids at 96 hr posttransfec-
tion were digested with either BamHI or with BamHI and
DpnI followed by electrophoresis and Southern detection
of the replicated copies. Signal intensities of the linearized
vectors were different because of the difference in recov-
ery of each plasmid byHirt extraction. Fragments of the Z6
region cloned into the pBSpuro vector showed various
degrees of replication (Figure 1B). As expected,
pBSpuroA3, containing three copies of TR, showed no
detectable replication without LANA expression, however,
replicated efficiently in LANA-expressing cells (Grundhoff
and Ganem, 2003; Hu et al., 2002). In contrast, fragment G
replicated in the absence of LANA, and, interestingly, the
replication efficiency was unchanged even in the pres-Cell Hoence of LANA (Figure 1B and Figure S1 in the Supplemen-
tal Data available with this article online.). However, it is
important to note that in LANA-expressing cells, the repli-
cation efficiency of the TR-containing plasmidswas higher
than the G fragment plasmids. Replication of the G frag-
ment-containing plasmid without LANA suggested the
presence of a LANA-independent origin referred to as an
autonomous replication origin and was further analyzed.
Plasmids Containing the KSHV G Fragment
Replicated in Primary Cells
The G fragment-containing vector (pBSpuroG) or empty
vector (pBSpuro) were transfected into primary human
foreskin fibroblasts (R2F), as well as Rat-1 and DG75
cell lines, to evaluate the replication potential of the G frag-
ment in primary cells and B cells. Hirt DNA extracted 96 hr
posttransfection, followed by digestion with either EcoRI
(E) or EcoRI and DpnI (E + D), revealed a DpnI-resistant
band, suggesting replication of the plasmid (Figure 1C).
Lack of a DpnI-resistant DNA band in empty vector
(pBSpuro)-transfected cells confirmed that the replication
of pBSpuroG was due to the G fragment (Figure 1C). DpnI
resistant bands in all the lanes were quantified as the
relative amount based on their respective inputs.
The pBSpuroG Plasmid Incorporates BrdU in
Synchronywith Host Cellular DNAduringReplication
Short-term replication assays demonstrated that the G
fragment can support replication of the plasmid in various
eukaryotic cell backgrounds. Therefore, we wished to
determine whether replication mediated by the G frag-
ment is synchronous to cellular DNA replication. We trans-
fected 20 million 293 cells with pBSpuroG or pBSpuro
vector and labeled the cells with 5-bromo-3-deoxyuridine
(BrdU) to increase the buoyant density of the replicated
DNA. During semiconservative replication, BrdU is incor-
porated into newly synthesized DNA, which forms a hybrid
of heavy:light (H:L) after one or two rounds of replication
and heavy:heavy (H:H) after two ormore rounds of replica-
tion. HEK293 cells which typically divide in 24 hr were
harvested at 0, 24, and 48 hr post-BrdU pulse to allow
sufficient time for no, one, and two rounds of replication,
respectively. Total DNA extracted from these cells were
subjected to CsCl density gradient centrifugation, and
the distribution of total DNA, a measure of BrdU incorpo-
ration, on the gradient was analyzed.
Figures 2A and 2B showed a peak at H:L (hemisubsti-
tuted) position within 24 hr of pulsed period after a single
round of cell division. DNA from the cells incubated with
BrdU for 48 hr showed a peak at H:H along with H:L, sug-
gesting a second round of replication substituting both
strands with H DNA. The distribution of density-labeled
DNA peaks were similar as seen in semiconservative
DNA replication (Aiyar et al., 1998; Schaarschmidt et al.,
2004). Quantitation of pBSpuroG DNA copies (based on
the relative amplification) in L:L, H:L, and H:H fractions
showed that plasmid DNA (Figure 2, black bars) peaked
at L:L in 0 hr BrdU-pulsed cells similar to cellular DNA
peaks detected based on the relative quantities of GAPDHst & Microbe 2, 106–118, August 2007 ª2007 Elsevier Inc. 107
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KSHV-Latent DNA ReplicationFigure 1. Evaluation of the Replication Potential of the Z6 Fragments
(A) Schematic of the KSHV genome and the fragments of Z6 cloned into pBSpuro.
(B) DpnI sensitivity assay of fragments A–H. Lanes B, 10% of the total Hirt’s DNA digested with BamHI; Lanes N, digested with NotI to linearize, and
Lanes B + D or N + D, digested with BamHI and DpnI or NotI and DpnI. Arrow indicates the pBSpuro spiked plasmid to test the completion of diges-
tion. Asterisks indicate the replicated copies of the plasmids. Relative quantities ofDpnI bands are shown in a bar diagram after normalizing the inputs
at 10%.
(C) DpnI analysis of pBSpuroG and pBSpuro into human foreskin fibroblast (R2F), Rat-1, and DG-75. DpnI-resistant band intensities were calculated
based on input at 5%, and the relative amounts of DpnI resistant bands are shown as bar diagram after normalizing against the background of
individual lane.in each fraction (Figure 2, gray bars). After 24 hr,
pBSpuroG shifted to the H:L peak, similar to the cellular
DNA (Figure 2, gray bars), which was further shifted to
the H:H peak after two rounds of replication (Figure 2C).
Relative copies of the pBSpuroG and cellular DNA in these
fractions demonstrated that the plasmid replicated in syn-
chrony with cellular DNA in a once-per-cell-cycle manner.
Empty vector, pBSpuro, showed a slight shift of the plas-
mid copies (from fraction 6 to 8/9) below that expected for
a single round of replication, suggesting that empty vector
was unable to replicate (Figure 2D). Cellular DNA in
pBSpuro-transfected cells showed similar peaks at L:L,108 Cell Host & Microbe 2, 106–118, August 2007 ª2007 ElsH:L, and H:H at 0, 24, and 48 hr post-BrdU pulse suggest-
ing that the cells were actively growing. After 48 hr with
two rounds of replication, pBSpuroG showed definite in-
corporation of BrdU in H:H fraction, whereas little or no
change was seen with the pBSpuro control. Therefore,
this result strongly supports that G fragment can mediate
replication.
The pBSpuroG Transfected in HEK293 Cells Persists
for Extended Periods as Episomal Plasmids
HEK293 cells were transfected with pBSpuroG and empty
vector. These plasmids yielded colonies after 3 weeks ofevier Inc.
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KSHV-Latent DNA ReplicationFigure 2. pBSpuroG Replicates in Synchrony with Cellular DNA
293 cells transfected with either pBSpuroG or pBSpuro were labeled with 30 mg/ml BrdU for 0, 24, or 48 hr. Total DNA extracted from these cells were
sheared and separated on CsCl gradient centrifugation. The distribution of total DNA from pBSpuroG (A) and pBSpuro (B) transfected 293 cells in all
16 fractions of CsCl density gradient after 0 hr, triangles; 24 hr, squares; and 48 hr, circles, were quantified using SYBR Green and plotted against
density of each fraction. Relative copies of the pBSpuroG (C) and pBSpuro (D) in each fraction, quantified in a semiquantitative PCR amplifying puro
gene as a target sequence, are shown as black bars. Relative distribution of the cellular DNA quantified based on the amplification of GAPDH gene is
shown as gray bars.selection with puromycin (2 mg/ml). pBSpuroG yielded
a significantly higher number (50–70 colonies) of colonies
as compared to the vector (5–10 colonies). These HEK293
colonies were amplified in culture and subjected to in situ
gel lysis analysis to determine the episomal nature of the
plasmid. Approximately 2 million cells from three indepen-
dent colonies selected for 5 weeks were analyzed by in
situ gel lysis. Southern analysis detected episomal
plasmid in the populations of pBSpuroG-selected
HEK293 cells similar to the bacterially replicated plasmid
(Figure 3A). The majority of the plasmid copies detected
were super-coiled, suggesting that these plasmids were
replicated and maintained independently (Figure 3A).
Colonies selected with pBSpuro vector did not show the
presence of plasmid bands, but a band of genomic sizeCell Hoswas detected. This suggested integration of the puromy-
cin plasmid DNA into the host genome providing puromy-
cin resistance and colony outgrowth. As control, purified
pBSpuro plasmid DNA was shown in lane 6 (Figure 3A).
To determine the approximate plasmid copies per cell,
chromosome spreads from four independent populations
of HEK293 containing pBSpuroG were prepared. In situ
hybridization using biotin-labeled probe followed by
detection with Streptavidin alexaflour 594 showed 6–12
copies of the plasmid per cell as an average of multiple
counts per colony of HEK293 (Figure 3B). The relative
copy number was lower than for latent KSHV-infected
cells (Cotter and Robertson, 1999). This suggested that
the plasmid containing G fragment was maintained as
an episomal DNA element. Nontransfected HEK293 cellst & Microbe 2, 106–118, August 2007 ª2007 Elsevier Inc. 109
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KSHV-Latent DNA ReplicationFigure 3. pBSpuroG Plasmid Persists as an Episomal DNA Detected by In Situ Cell Lysis
(A) In situ cell lysis analysis of the long term selected clones. Left panel shows EtBr stained gel that was transferred onto the gene screen membrane
hybridized using 32P-labeled puro probe (right panel) that showed the presence of different forms of the plasmid. Lanes 1, 2, and 3 are the pBSPuroG
plasmid selected clones; lane 4 is purified pBSpuroG (3 ng); lane 5 clones with pBSpuro plasmid; and lane 6 is the purified pBSpuro (3 ng). Chr DNA is
the chromosomal DNA. Arrows indicate the plasmids pBSpuroG and pBSpuro in respective lanes. Triangles indicate the hybridization signal of
chromosomal DNA in pBSpuro plasmid selected clone.
(B) Localization of pBSpuroG in long-term selected colonies by fluorescence in situ hybridization. Chromosome spreads of pBSpuroG selected cells
were hybridized with biotin-labeled probe and detected with streptavidin conjugated Alexa flour 594 (red dots). Chromosome spreads of HEK293
cells were used as a control. Average number of hybridizing dots per chromosome calculated based on 10 optical fields is presented.
(C) Long-term selected pBSpuroG plasmids replicated in its native form. DpnI sensitivity assay of Hirt DNA extracted from four long-term selected
clones (clones 1–4). Lane E (EcoRI) and E + D (EcoRI andDpnI) pBS was added in each reaction to test for the completion of digestion. The number of
colonies was yielded after transformation of the DpnI- digested Hirt DNA extracted from pBSpuroG and pBSpuro clones.
(D) Restriction patterns of the isolated plasmid from the transformants with BamHI and PstI. Lane 1 is pBSpuro, lane 2 is pBSpuroG, and lanes 3–10
are plasmid DNA isolated from the colonies yielded with DpnI digested long term selected Hirt DNA.used as a control did not show any hybridization
(Figure 3B).
Long-Term Maintenance Is Due to the Replication
of pBSpuroG with a Functional cis-Acting
Replication Origin
Hirt DNA isolated from pBSpuroG colonies after selection
for 5 weeks were subjected to DpnI sensitivity analysis.
This analysis showed DpnI-resistant copies of the
pBSpuroG plasmid whereas pBS, the spiked control
DNA, was completely digested (Figure 3C). This suggests
that the pBSpuroG plasmid persisted following replication
during successive rounds of cell division. G fragment was
cloned into pBluescript to test the replication mediated by
the G fragment in the absence of the Pac gene to avoid
selection of puromycin. The DpnI analysis of the isolated
DNA without selection also showed similar replication
efficiencies (Figure S2). These data suggests that the G
fragment can support replication and is likely to contribute
to replication of the KSHV genome.110 Cell Host & Microbe 2, 106–118, August 2007 ª2007 ElseThe pBSpuroG Plasmid Replicates in Its Native
Form under Long-Term Selection
To determine whether episomally maintained pBSpuroG
in long-term selected cells is replicated in its native form,
the DNA extracted from four long-term selected colonies
were subjected to DpnI digestion. Transformation of the
digested plasmid DNA into E. coli yielded a significant
number of ampicillin-resistant colonies (Figure 3D).
Restriction pattern of the plasmids isolated from these
colonies matched the parental pBSpuroG, demonstrating
that the replicated plasmid was maintained in its native
form (Figure 3D). Furthermore, digested Hirt DNA from
control pBSpuro-selected HEK293 cells did not transform
E. coli to produce ampicillin-resistant colonies.
To determine if the recovered plasmids were defective
or altered during our analysis, we sequenced 4 plasmids
obtained from individual colonies. The analysis showed
that recovered plasmids had identical nucleotide
sequence as the parental input plasmid and confirmed
the integrity of the plasmids (Figure S3).vier Inc.
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(A) Schematic of the G fragment DNA sequence which lies between 24877–25713 nt on KSHV coordinates (Russo et al., 1996).
(B) Hirt DNA extracted from 293 cells transfected with G, AT, or K5 fragments was digested with EcoRI (5%, to linearize) or EcoRI +DpnI and hybrid-
ized with 32P labeled ampicillin gene probe. The DpnI-resistant bands were quantified. Intensities of input EcoRI lanes were set to 5, and relative
intensities ofDpnI band in each lane was calculated based on the respective inputs bands after normalizing against the background of individual lane.
(C) AT region of the G fragment containing plasmid (pBSpuro gAT) and another similar length (760 bp) control AT region of KSHV genome containing
plasmids (pBSpuro cAT) were transfected into 293 cells for DpnI sensitivity assay. 10% of the total Hirt DNA was digested with EcoRI and 90% with
E + D.An AT-Rich Region of the G Fragment Supports
Replication
Sequence analysis of the G fragment revealed the pres-
ence of a noncoding, AT-rich region adjacent to the cod-
ing sequence of K5 (Figure 4A). The replication potential
of the AT and K5 regions were analyzed and showed
a DpnI-resistant band in the AT region containing plasmid
(Figure 4B, lane 4). A plasmid containing the K5 region did
not show a DpnI-resistant band (Figure 4B, lane 6). The
pBS-G parental plasmid, as expected, showed almost
similar efficiency of replication suggesting that the AT
region is likely to be the predominant region responsible
for replication. The pBS vector was used as a control for
transfection and replication in this assay. The relative
densities of the bands were plotted after subtracting the
respective background from each.
To confirm that the AT region of the G fragment can
support replication, we cloned a similar size fragment of
the Z6 fragment with similar AT content (52%) into
pBSpuro (pBSpuro cAT). Scanning analysis representing
GC content of the control region is shown as Supplemen-
tal Data (Figure S4). Comparison of the replication efficien-
cies of the control AT (pBSpuro cAT) and the AT region of
the G fragment containing plasmids (pBSpuro gAT)
revealed almost negligible signal in pBSpuro cAT, indicat-
ing lack of replicated DNA as compared to the AT region of
the G fragment (Figure 4B). This suggests that the DNA
sequence present in the AT region of the G fragment,
not the AT content, is important for DNA replication.Cell HoORC2 and MCM3 Associate with Complexes
Containing the cis-Acting AT-Rich Element
within the KSHV Genome
To determine whether the human replication machinery
accumulates in vivo at the chromatin of KSHV AT-rich
region, we performed chromatin immunoprecipitation
(ChIP) analysis on G1/S and G2/M cells fractionated using
centrifugal elutriation (Figure 5A). KSHV-positive PELs
(2 3 109 cells) were subjected for centrifugal elutriation
and approximately 2 3 108 cells collected in G1/S and
G2/M cell-cycle phases were subjected to chromatin
immunoprecipitation using human a-ORC2, a-MCM3
antibody, and a matched control. A fraction of immuno-
precipitated chromatin was subjected to western blot
analysis to detect the specific proteins (Figure 5B). Quan-
titation of AT-rich region DNA in a real-time PCR assay in
the chromatins of G1/S cells immunoprecipitated with a-
ORC2 and a-MCM3 antibodies showed significant copies
of the AT-rich region (Figure 5D). The three KSHV-positive
cell lines (BC3, BCBL-1, and JSC-1) showed similar pat-
terns of ORC2 and MCM3 binding to the chromatin of
the AT-rich region. Interestingly, chromatin immunopre-
cipitated with a-ORC2 antibodies brought down AT-rich
DNA from G2/M phase cells, suggesting that ORC2
remained associated with the DNA throughout the cell
cycle. In contrast, MCM3 antibodies showed consistent
reduction in the amount of immunoprecipitated AT-rich
region in the G2/M phase cells suggesting phase-specific
association of MCM. A higher number of AT-rich DNAst & Microbe 2, 106–118, August 2007 ª2007 Elsevier Inc. 111
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KSHV-Latent DNA ReplicationFigure 5. The AT Region of the G Fragment Immunoprecipitated with Components of the Cellular Replication Machinery in ChIP
Assay
(A) Representative FACS profile of the elutriated PEL cells in G1/S and G2/M phases.
(B) Representative western blots showing immunoprecipitation of chromatin using a-ORC2 and a-MCM3 antibodies (lane 3). Lane 2; control IgG did
not immunoprecipitate chromatins nonspecifically. Lane 1; input (10% total chromatin). Lane 4; proteins in post-ChIP.
(C) Coordinates of the KSHV genome indicating E and G regions.
(D) Quantitation of the relative copies of AT region of the G fragment and control E fragment in a-ORC2 and a-MCM3 antibodies immunoprecipitated
chromatin from PELs (BC-3, BCBL-1, and JSC-1). Immunoprecipitated AT and E copies were calculated based on the copies in input lane (10%).
(E) The AT region of G but not the control AT region was immunoprecipitated with anti-ORC2 and anti-MCM3 antibodies in ChIP assay. Amplification
of puro gene (adjacent to the G, AT, or K5 region) in the DNA recovered from immunoprecipitated chromatins of 293 cells transfected with pBSpuroG,
pBSpuroAT, and pBSpuroK5 and pBSpuro using a-ORC2 and a-MCM3 antibodies. Relative amounts of amplicon in immunoprecipitated chromatins
were quantified based on the intensity of amplification of the target region.
(F) Cellular ORC2 andMCM3 do not bind to control AT region of KSHV genome.Western blot shows immunoprecipitation of chromatins with a-ORC2
and a-MCM3 antibodies from pBSpuro gAT and pBSpuro cAT. DNA from chromatins of pBSpuro cAT did not show any amplification (lanes 7 and 8)
as compared to pBSpuro gAT (lanes 3 and 4), suggesting specific recruitment of cellular proteins at gAT region of the KSHV genome.copies with MCM3 antibodies in G1/S phase cells
suggests that MCM associate with the replication origin
during the synthesis (S) phase, similar to cellular DNA
replication (Bell and Dutta, 2002).
An adjacent region in the G fragment, K5 ORF, did not
show any amplification (Figure S5) of the target. Thus,
the AT region is most likely the site for association of the
replication proteins (Figure 5D). Another region of the Z6
cosmid, E fragment, which did not replicate in our tran-
sient replication assays, was used as control for ChIP
and failed to show amplification of the target region by
ChIP with a-ORC2 and a-MCM3 antibodies. (Figures 5C
and 5D, E region). Thus, ORCs and MCMs binding were
specific in terms of their association to the chromatin on
the DNA of the G region fragment.
To further confirm the binding of host replication
machinery at the AT region of G fragment, we transfected
pBSpuroG, pBSpuroAT, pBSpuro K5, and pBSpuro
plasmids separately into 293 cells. Forty-eight hours post-
transfection, chromatins prepared from the above trans-
fected cells were immunoprecipitated using a-ORC2112 Cell Host & Microbe 2, 106–118, August 2007 ª2007 Elsevieand a-MCM3 antibodies. Western blot analysis detected
the immunoprecipitation of the respective proteins
(Figure S6). PCR amplification of the specific regions G,
AT, and K5 on the plasmids immunoprecipitated by
ChIP revealed amplification of the AT region but not the
K5 region of the G fragment (Figure 5E).
The AT-Rich Region within the G Fragment
Is Specific for Recruiting ORC2 and MCM3
To confirm the binding of cellular replication machinery
proteins to the AT region of the G fragment, we performed
chromatin immunoprecipitation from 293 cells transfected
with either pBSpuro gAT or a control AT rich region from
the KSHV LUR referred to as pBSpuro cAT. DNA extracted
by ChIP using a-ORC2 and a-MCM3 antibodies revealed
amplification of target DNA from cells with plasmids
containing the G fragment AT-rich region, but not the con-
trol AT region plasmid (Figure 5F). Binding of ORC2 and
MCM3 to the chromatin structure of the AT region of the
G fragment was further reproduced in the B cell back-
ground (DG75) (Figure S7).r Inc.
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Due to Replication in Eukaryotic Cells
BrdU was used to pulse HEK293 cells transfected with
plasmids pBSpuroG, pBSpuroTR with LANA expression
(positive control), and pBSpuro (negative control).
Twenty-four hours posttransfection, cells were pulsed
with BrdU (50 mM), followed by extraction of the plasmid
DNA using modified Hirt’s procedure. Figure 6A shows
the schematic of the BrdU labeling and immunoprecipita-
tion using a-BrdU antibody. A fraction of Hirt DNA (10%)
was used as input (Figure 6A, lane 1). Relative copies of
plasmid DNA quantified by semiquantitative PCR in the
immunoprecipitated samples showed that a-BrdU anti-
bodies immunoprecipitated the G fragment (Figure 6A,
pBspuroG, lane 3) but not the control IgG (Figure 6A,
pBSpuroG, lane 2). TR containing plasmid, which sup-
ports replication in the presence of LANA (Grundhoff and
Ganem, 2003; Hu et al., 2002), was immunoprecipitated
by the a-BrdU antibody (Figure 6A, pBSpuroTR + LANA,
lane 3). BrdU incorporation in the plasmids containing G
and TR suggested that both contained an origin of replica-
tion. However, the G fragment plasmid incorporated BrdU
at a lower efficiency than the TR with LANA (Figure 6A).
The pBSpuro vector-transfected cells pulsed with BrdU
failed to show detectable levels of vector DNA, confirming
that pBSpuro was unable to replicate (Figure 6A,
pBSpuro).
Since copies of BrdU-labeled G fragment was lower
compared to the TR plasmid with LANA, we wanted to de-
termine the replication efficiencies of these two plasmids
with and without LANA expression. DpnI sensitivity assay
performed on Hirt DNA extracted 96 hr posttransfection
revealed replication of pBSpuroG in the absence of
LANA, although at lower levels compared to pBSpuroTR
plus LANA (Figure 6B). Interestingly, replication mediated
by the G fragment was unaffected by LANA expression
compared to TR-mediated replication.
Depletion of ORC2 Abolished Replication
of the G Fragment Containing Plasmids
ORC2-specific siRNA was used to deplete endogenous
ORC2 in 293 cells. Levels of ORC2 after 96 hr post-
transfection showed a significant reduction in ORC2
protein levels in specific ORC2 siRNA treated cells
but not in a scrambled siRNA treated cells (Figure 6C,
compare lanes 1 and 2). pBSpuroG was transfected
into either specific or scrambled (SCR) siRNA-treated
cells and allowed for replication along with BrdU to
label the replicating DNA. Hirt DNA extracted 96 hr
posttransfection from these cells were digested with
DpnI and subjected to a-BrdU immunoprecipitation.
ORC2-depleted cells had no detectable levels of
immunoprecipitated DNA, suggesting absence of repli-
cation activity of the plasmid in ORC2 lacking cells. In
contrast, scrambled siRNA-transfected cells showed
amplification suggesting involvement of cellular ORCs
as a component of the replication machinery (Fig-
ure 6D).Cell HoLoss of Replication Efficiency Was Complemented
by the G Fragment in a Replication Deficient TR
Containing Plasmid
To evaluate the biological significance of replication medi-
ated by the G fragment, we used a plasmid-based strat-
egy. We used a replication-deficient TR (DRE 512–
556 bp) (Figure 6E) (Hu and Renne, 2005) containing
plasmid to determine whether the replication origin of
the G fragment is able to complement the replication func-
tion of theDRE TR-containing plasmid.We clonedDRE TR
into a GFP pBSpuro (puro-GFP) plasmid followed by in-
sertion of the G fragment to produce puro-GFP + DRE
TR + G (Figure 6F). These plasmids were transfected
into HEK293 cells and assayed for replication after 96 hr.
Extracted DNA was digested with EcoRI or EcoRI +
DpnI, followed by detection of DpnI-resistant copies in
a quantitative PCR assay using primers that amplified
only DpnI-resistant copies. The relative copies of the
DpnI-resistant plasmids were calculated by normalizing
the input to 10 (10% of the total Hirt DNA). Puro-GFP +
G yielded DpnI-resistant copies similar to previous panels
(Figure 5B). DRE TR-containing plasmid was unable to
replicate. Interestingly, the plasmid with DRE TR contain-
ing the G fragment (puro-GFP DRE TR + G) yielded DpnI-
resistant copies suggesting that the G fragment was able
to complement the replication ability of the plasmid
(Figure 6H).
HEK293 cells transfected with the above plasmids were
subjected to puromycin selection for 3 weeks to evaluate
long-term replication by the G fragment in DRE TR plas-
mids. This was assayed by counting the puromycin-resis-
tant colonies produced after subsequent replication of the
plasmid. Plasmids puro-GFP-G and puro-GFPDRE TR +
G yielded almost similar number of colonies (Figure S8)
but not the puro-GFP-DRE TR plasmid.
Single Molecule Analysis of Replicated DNA Showed
Replication Initiation within the G Fragment
of the KSHV Genome
To visualize the individually replicated DNAmolecules, we
used a recently described technique, single molecule
analysis of replicated DNA (SMARD) (Norio and Schildk-
raut, 2001). In this assay, we used 50-Iodo-20-deoxyuridine
(IdU) and 50-chloro-20-deoxyuridine (CldU) to label
pBSpuroG and pBSpuro transiently transfected 293 cells.
Seventy-two hours posttransfection, cells were labeled
with IdU to completely label the entire plasmid length,
followed by removing IdU and pulsing with CldU for
2 hours. A schematic illustration of double labeling is
shown in Figure 7A. Stretched DNA molecules were
detected by hybridization with biotin-labeled probes and
further detected using Streptavidin-conjugated Alexa
Flour 594 (red). Incorporated IdU (first label) was detected
using a-IdU antibody followed by Alexa Flour 350 (blue)
(Figure 7B). Transition from the first label (IdU) to the sec-
ond label (CldU) was detected using rat a-CldU antibody
and Alexa Flour 488 (green) antibody. Blue signal detect-
ing the incorporation of IdU was seen throughout the
entire length of the pBSpuroG, and no detectable signalst & Microbe 2, 106–118, August 2007 ª2007 Elsevier Inc. 113
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KSHV-Latent DNA ReplicationFigure 6. The pBSpuroG Actively Incorporates BrdU and Failed to Replicate in ORC2-Depleted Cells
(A) A schematic of BrdU incorporation and immunoprecipitation of BrdU-labeled DNA. a-BrdU antibody immunoprecipitated BrdU incorporated
newly synthesized DNA from TRwith LANA expression as well as G fragment containing plasmid detected by the amplification of immunoprecipiated
DNA in lanes 3. Lane 1, input; and lane 2, immunoprecipitation of BrdU-labeled DNA with control IgG. Vector control (pBSpuro) did not show detect-
able level of amplification.
(B) G fragment containing plasmid replicates in the absence of LANA. DpnI sensitivity assay of Hirt DNA extracted from 293 cells transfected with
pBSpuroTR and pBSpuroG either with (+) or without () LANA expression. Quantitation of DpnI-resistant copies based on input, 10% in EcoRI lanes.
(C) Western blots showing efficient depletion of ORC2 expression in ORC2 specific siRNA and scrambled siRNA (SCR)-transfected 293 cells.
(D) Evaluation of pBSpuroG-mediated replication by BrdU incorporation in 293 cells depleted with ORC2. a-BrdU antibody failed to immunoprecip-
itate G fragment containing plasmid from ORC2 siRNA-treated cells (lane 3, ORC2 siRNA), whereas scrambled siRNA (SCR siRNA)-treated cells
showed immunoprecipitation of BrdU labeled DNA (lane 3). Lane 4 is control DNA for amplification, and lane 5 had water as a negative control.
(E) TR Sequence alignment to show deletion of 512–556 bp for RE deletion. LBS1, LANA-binding sequence.
(F) DpnI sensitivity assay of the puro-GFP plasmid containing WT TR or DRE TR in LANA-expressing cells. Ninety-six hours posttransfection, low
molecular weight DNAwas extracted and digestedwith either EcoRI (10%) or with EcoRI+DpnI. TR containing plasmids showed replication; however,
DRE TR did not.
(G) Schematic of the plasmids used in replication and complementation assay.
(H) Real-time quantitation of the DpnI-resistant plasmid copies. DpnI-digested DNA was quantified using a primer pair flanking a DpnI restriction site.
10% of the total Hirt DNA was digested with EcoRI and used to calculate the relative amounts of DpnI resistant copies in respective lanes.114 Cell Host & Microbe 2, 106–118, August 2007 ª2007 Elsevier Inc.
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KSHV-Latent DNA ReplicationFigure 7. Single Molecule Analysis of the Replicated DNA
(A) Schematic showing incorporation of nucleotides in DNA containing origin of replication (ori) site.
(B) Images of three PmeI linearized pBSpuroG DNA molecules. The hybridization signal detected pBSpuro backbone, shown in red. G fragment
cloned at BamHI sites of pBSpuro is flanked by regions of pBSpuro and shows no hybridization signal. The incorporation of IdU was detected by
a-IdU antibody followed by Alexa Flour 350 (blue) showing labeling of the entire length of the molecule after one round of replication. CldU detected
by anti-CldU showed the transition site, which is most likely the initiation site for the DNA replication. Varying length of CldU labeling was detected in
these three molecules. pBSpuro lacking G region did not show incorporation of any halogenated nucleotides due to the lack of replication initiation
sites. Hybridization signals detecting pBSpuro vectors are shown in red.
(C) Graphic representation of the number of molecules showing incorporation of IdU and transition to CldU in pBSpuroG and empty vector, pBSpuro.
(D) Proposed model of KSHV persistence with a LANA-independent origin of replication. LANA tethers the viral genome to the host chromosome and
persists as highly ordered chromatin structure (Stedman et al., 2004; Verma et al., 2006). Binding of ORCs and MCMs at the G region of the KSHV
most probably allows binding of other proteins of replication machinery to make pre-RC for latent replication of the KSHV genome.for IdU was seen in pBSpuro vector (Figure 7B). Identifica-
tion of transition sites due to incorporation of CldU at the
replication initiation site was predominantly detected in
the G region, which may serve as a replication initiation
site (Figure 7B). Analysis of over 100 DNA molecules in
each of four independent experiments showed IdU incor-
poration in about 10% of the molecules, as would be
expected (Verma et al., 2006). However, the majority of
molecules undergoing replication (IdU incorporation)
showed transition from IdU to CldU, indicating replication
initiation within the G fragment. Three DNA molecules
representing incorporation of IdU and CldU are shown
(Figure 7B). Pulsing with the second label was allowed
only for a brief period (2 hr) so that a stretch of DNA can
be predominantly labeled to identify the replication initia-
tion sites. This replication initiation site was also confirmed
on pBSpuroG molecules using different regions of the
plasmid as probe (Figures S9A and S9B). Taken together,Cell Hosthe SMARD data supports our hypothesis that the G
region of the KSHV DNA can also serve as a replication
initiation site (Figure 7C). The pBSpuro vector transfected
and labeled in a similar manner did not show any detect-
able incorporation of the halogenated nucleotides.
DISCUSSION
This study focuses on the identification of potential latent
origin of replication at the left 33 kbp region of the KSHV
genome (Russo et al., 1996). Previous replication assays
have identified a region in the 33 Kbp cosmid which
included the terminal repeats that supported replication
with concordant expression of LANA (Ballestas et al.,
1999). Interestingly, the G fragment of this cosmid (the G
fragment) did not show a dependence on LANA for repli-
cation. Thus, it is considered to contain an autonomously
replicating cis-acting DNA element. Replication mediatedt & Microbe 2, 106–118, August 2007 ª2007 Elsevier Inc. 115
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as primary, cell lines, suggesting the presence of a poten-
tial replication origin. Plasmids containing the G fragment
incorporated BrdU and replicated in a cell-cycle-depen-
dent manner. This region also supported long-term repli-
cation of plasmids as determined by selection of trans-
fected HEK293 cells. Colonies yielded after selection
showed the presence of replicated, unrearranged
episomal plasmids, suggesting the presence of a cis-
acting element capable of recruiting replication initiation
proteins.
The precise function of LANA in replication of the KSHV
genome is still unresolved. Recent studies suggest that
LANA recruits the host cellular replication machinery at
the TR and tethers the KSHV episomes to the host
chromosomes (Barbera et al., 2006; Verma et al., 2006).
Additionally, depletion of LANA did not completely abolish
the episomes from PELs, suggesting the presence of
LANA-independent replication origins (Godfrey et al.,
2005). Similarly, HVS lacking identified replication origins
are capable of establishing latent infection (Kung and
Medveczky, 1996). This suggests that these herpesvi-
ruses do not have an absolute requirement for a particular
origin, although they may contain a dominant element.
There is likely to be flexibility where a number of additional
sites can initiate replication. Additionally, Bovine Papillo-
mavirus 1 persisted in a murine mammary tumor virus-de-
rived line independent of E1, suggesting the involvement
of cellular proteins (Kim and Lambert, 2002). Incorporation
of halogenated nucleotides and detection of single epi-
somes of EBV have suggested the presence of noncon-
served multiple replication initiation sites throughout the
genome (Norio and Schildkraut, 2004). Identification of
autonomous replication regions in the KSHV genome
suggests that latent viral DNA replication can start at the
identified sites which can progress to complete the repli-
cation of the entire genome. One primary function of
LANA appears to be tethering of the viral genome to the
host chromosome, thus ensuring efficient segregation.
KSHV mutants have yet to be identified, which may yield
interesting information regarding the viability of the virus
in various cell types as well as under fluctuating immune
status of the patients. Since LANA is a highly immuno-
genic protein, the host immune system is likely to recog-
nize infection by detection of LANA and thus, set up
defenses to inhibit viral propagation. However, it has
been established that once KSHV infects the host B or
endothelial cells, it can persist and reactivate if the immu-
nity is compromised (Moore and Chang, 2003). To main-
tain viral DNA at desired copy numbers in immune compe-
tent patients, these autonomously replicating elements
are likely to play a functional role in replication of the
KSHV genome.
This study demonstrates that the KSHV genome
contains an autonomous replicating cis-acting sequence,
which can support replication of plasmids without a
eukaryotic replication origin in the background of various
cell types as determined by multiple assays. The replica-
tion of the G fragment containing plasmid requires the116 Cell Host & Microbe 2, 106–118, August 2007 ª2007 Elsevcellular replication machinery, as ORC2 depleted cells
did not support replication performed in short-term as-
says. Incorporation of halogenated nucleotides (IdU and
CldU) suggests that DNA replication can initiate at the G
region. This identified region (G) can also support the
long-term replication of plasmid DNA in culture. This
replication zone lies within a 750 bp region between the
20/30 bp GC repeats and the K5 ORF and is rich in AT
with some specificity for this particular AT-rich element.
Further mutational analysis, however, is needed to delin-
eate the function of specific cis-elements within this region
in the replication process. These results have important
implications for understanding the functional variation as-
sociated with eukaryotic origins of replication and may
also facilitate the construction of a first generation
KSHV-based gene therapy vector for ex vivo amplification
and transfer into affected patients without the caveat of
integration into the host genome.
EXPERIMENTAL PROCEDURES
Cloning of Z6 Fragments into pBSpuro
pBSpuro was constructed by subcloning the puromycin resistance
expression cassette from pBABEpuro to the SalI and Cla I sites of
the pBluescript (Stratagene) multiple cloning site. Cloning procedure
of subfragments of Z6 cosmid and short-term replication assay is
described in the Supplemental Data.
Separation of BrdU-Labeled DNA in CsCl Density Equilibrium
Plasmids, pBSpuroG, and pBSpuro were transfected into 23 107 293
cells and labeled with BrdU as described before with slight modifica-
tion (Aiyar et al., 1998; Schaarschmidt et al., 2004). Briefly, 24 hr post-
transfection cells were pulsed with BrdU (30 mg/ml) and incubated for
24 and 48 hr to allow one or two rounds of replication, respectively. To-
tal DNA from these cells were sonicated and resolved on CsCl gradient
as described in the Supplemental Data.
Long-Term Selection and In Situ Gel Lysis
10 mg of pBSpuroG was transfected into 5 million 293 cells and plated
in a 100 mm plate. Transfected cells were selected using puromycin
(1.0 mg/ml) for 3 weeks, which resulted in the outgrowth of colonies.
These colonies were further subcloned and analyzed by in situ lysis
gels to determine the episomally maintained DNA (Gardella et al.,
1984).
Preparation of Chromosome Spread and In Situ Detection
of Plasmids
Colonies selected with pBSpuroG and 293 cells were mitotically
arrested by colchicine treatment, and the chromosome spreads
were prepared as described previously (Verma and Robertson,
2003b). Chromosomes were aged at RT, and pBSpuroG was detected
using biotin-labeled pBSpuro DNA as a probe. Probes were hybridized
overnight at 37C, followed by detection with tyramide-rhodamine sig-
nal amplification system (Perkin-Elmer). Chromosomes were stained
with DAPI; red dots that are the site of probe hybridization represent
individual copies of plasmids.
Analysis of the Plasmid Isolated from Long-Term
Selected Colonies
Low molecular weight DNA was extracted from pBSpuroG long-term
(5 weeks)-selected clones and digested with either EcoRI or EcoRI
and DpnI having been spiked with pBS plasmid as a control for diges-
tion. The digested product was resolved on 0.8% agarose gel and
transferred to gene screen for detection of replicated copies using
pBSpuro backbone as probe. 10% of the digested product wasier Inc.
Cell Host & Microbe
KSHV-Latent DNA Replicationtransformed into E. coli and selected for the colonies on ampicillin
plates. The plasmids from the transformants were isolated and the
restriction patterns were analyzed using BamHI and PstI restriction
endonucleases.
Analysis of pBSpuroG Sequence and Short-Term
Replication Assay
Nucleotide sequences of G fragment (24877–26841) (Neipel et al.,
1997; Russo et al., 1996) were analyzed. This region contains a unit
of 20–30 bp GC repeats downstream to this region there is an AT-
rich region. Fragment G also encodes for the K5 ORF (25713–26483)
which is BHV4-IE1 homolog of EBV (Russo et al., 1996). AT region
and K5 ORF region were cloned separately in same vector backbone
by digesting the G fragment with AccI.
Centrifugal Elutriation and Chromatin Immunoprecipitation
Assay
Centrifugal elutriation was used to separate the cells in different cell-
cycle phases as described previously (Ritzi et al., 2003). For ChIP,
experiments 2 3 108 cells in G1/S or G2/M were crosslinked with
1% formaldehyde for 10 min. Chromatin immunoprecipitation (ChIP)
assay was performed as described by Shang et al. with slight modifi-
cation (Shang et al., 2000), and a detailed method of chromatin immu-
noprecipitation and primers used for amplification of the respective
region are described in the Supplemental Data.
RNA Interference
The siRNA for ORC2 was designed using BLOCK-iT RNAi express
siRNA designing tool (Invitrogen, Inc., Carlsbad, CA). siRNA ORC2
(50-AUCCUGAGAUUACGAUAAA-30 ) and control luciferase (50-
CUUACGCUGAGUACUUCGA-30) (Prasanth et al., 2004) were trans-
fected at 100 nM final concentration with oligofectamine according
to manufacturer’s instruction (Roche Inc.). Twenty-four hours post-
transfection cells were trypsinized and replated followed by transfec-
tion with 100 nM siRNA and pBSpuroG using Lipofectamine2000 as
per manufacturer’s recommendation (Invitrogen).
BrdU Labeling and Immunoprecipitation of Replicated DNA
293 cells (107) transiently transfected with pBSpuroG or pBSpuro were
selected with puromycin for 72 hr followed by addition of 50 mM BrdU
in exponentially growing cells. Four hours later, cells were harvested
and washed twice in cold PBS. Plasmid DNA extracted from these
cells was subjected for immunoprecipitation using anti-BrdU antibody
described in the Supplemental Data.
IdU and CldU Labeling of Replicating DNA and Stretching
of Labeled DNA on Glass Slide
293 cells transfected with pBSpuroG or pBSpuro were used for detec-
tion of replicated DNA using SMARD. Exponentially growing cells were
pulsed with 25 mMof IdU (Sigma-Aldrich) for 20 hr, followed by collect-
ing the cells by centrifugation and incubating them with the medium
containing 25 mM CldU for 2 hr (Norio and Schildkraut, 2004). Low
molecular weight DNA was extracted by modified Hirt’s procedure
followed by digestion with PmeI to linearize the plasmids and purified
on 0.6% agarose.
Gel-purified dually labeled DNA was resuspended in printing buffer
(33 SSC) and stretched on poly L-lysine coated slides (Erie Scientific).
DNA molecules were immobilized on the slides by baking at 85C for
1 hr. DNA was visualized by hybridizing with biotin-labeled probe
(NEB). Biotin was detected using Streptavidin conjugated with Alexa
Flour 594 (red) (Molecular Probes). Incorporated IdU was detected
using Mouse a-IdU (Becton Dickinson Inc.) as primary antibody
(monoclonal), and Alexa Fluor 350 (blue) conjugated goat a-mouse
(Molecular Probes) as secondary antibody. CldU was detected using
rat anti-CldU (Accurate Chemicals, Westbury, NY) and goat anti-rat
conjugated with Alexa Flour 488 (green) secondary antibody. DNA
molecules were visualized using Olympus BX60 fluorescence micro-Cell Hosscope and photographs captured using Pixel Fly digital camera
(Cooke Inc. Auburn Hills, MI).
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
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